-
My Account
My Account
BSE Live
May 16, 16:01Prev. Close
326.45
Open Price
329.00
Bid Price (Qty.)
320.10 (2)
Offer Price (Qty.)
321.50 (20)
NSE Live
May 16, 15:57Prev. Close
326.15
Open Price
326.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
319.90 (540)
| Yearly Results of Biocon (in Rs. Cr.) | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | |
| Net Sales/Income from operations | 1,738.20 | 2,028.40 | 1,988.40 | 2,884.70 | 2,419.20 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 1,738.20 | 2,028.40 | 1,988.40 | 2,884.70 | 2,419.20 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 912.30 | 760.70 | 858.20 | 1,278.50 | 958.70 | |
| Purchase of Traded Goods | 1.70 | 0.90 | 0.90 | 125.40 | 92.50 | |
| Increase/Decrease in Stocks | -105.80 | 36.70 | -31.40 | -147.10 | -1.80 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 367.70 | 390.20 | 344.80 | 510.30 | 408.60 | |
| Depreciation | 108.20 | 103.50 | 98.00 | 147.10 | 136.10 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 501.20 | 527.40 | 529.90 | 732.00 | 643.00 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -47.10 | 209.00 | 188.00 | 238.50 | 182.10 | |
| Other Income | 187.20 | 150.20 | 201.70 | 117.50 | 124.70 | |
| P/L Before Int., Excpt. Items & Tax | 140.10 | 359.20 | 389.70 | 356.00 | 306.80 | |
| Interest | 0.40 | 0.40 | 1.20 | 2.60 | 1.00 | |
| P/L Before Exceptional Items & Tax | 139.70 | 358.80 | 388.50 | 353.40 | 305.80 | |
| Exceptional Items | -- | -- | 159.70 | 198.70 | -- | |
| P/L Before Tax | 139.70 | 358.80 | 548.20 | 552.10 | 305.80 | |
| Tax | 53.60 | 78.30 | 111.90 | 59.40 | 67.30 | |
| P/L After Tax from Ordinary Activities | 86.10 | 280.50 | 436.30 | 492.70 | 238.50 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | 4.60 | -- | -- | |
| Net Profit/(Loss) For the Period | 86.10 | 280.50 | 440.90 | 492.70 | 238.50 | |
| Equity Share Capital | 600.30 | 600.00 | 600.00 | 300.00 | 300.00 | |
| Reserves Excluding Revaluation Reserves | 7,492.60 | 7,306.20 | 6,936.40 | 6,814.50 | 6,437.70 | |
| Equity Dividend Rate (%) | 10.00 | -- | 10.00 | 10.00 | 20.00 | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 0.72 | 2.36 | 3.72 | 8.33 | 4.04 | |
| Diluted EPS | 0.72 | 2.34 | 3.71 | 8.27 | 4.02 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 0.72 | 2.36 | 3.72 | 8.33 | 4.04 | |
| Diluted EPS. | 0.72 | 2.34 | 3.71 | 8.27 | 4.02 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
29.04.2022
Biocon Consolidated March 2022 Net Sales at Rs 2,408.80 crore, up 31.01% Y-o-Y
29.04.2022
Biocon Standalone March 2022 Net Sales at Rs 517.70 crore, up 5.31% Y-o-Y
25.01.2022
Biocon Standalone December 2021 Net Sales at Rs 473.00 crore, up 3.71% Y-o-Y
24.01.2022
Biocon Consolidated December 2021 Net Sales at Rs 2,174.20 crore, up 17.46% Y-o-Y
Copyright © e-Eighteen.com Ltd All rights resderved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express writtern permission of moneycontrol.com is prohibited.
